Viome Life Sciences partnered with Scripps Research to develop and validate an at-home RNA-based screening test aimed at detecting precancerous colon polyps, facilitating early prevention of colorectal cancer. The 1,000-patient observational clinical study will analyze stool and saliva samples using RNA sequencing to identify gene expression signatures correlating with polyp presence. Success could lead to a non-invasive, accessible screening platform potentially approved as a standard of care by the FDA.